logo

For the Inventor, By the Inventor

Lyngby, Denmark

Lise Brown Christiansen

This inventor holds 19 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Novo Nordisk A/s, High Point Pharmaceuticals, LLC, Karo Bio Ab. Active years: 1999-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lise Brown Christiansen. Retrieved from https://idiyas.com/inventor/lise-brown-christiansen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 52.6



Average Co-Inventor Count = 4.5

ph-index = 11

Forward Citations = 552(Granted Patents)


Company Filing History:

goldMedal15 out of 1,803 
 
Novo Nordisk A/s
 patents
silverMedal4 out of 50 
 
High Point Pharmaceuticals, LLC
 patents
bronzeMedal1 out of 34 
 
Karo Bio Ab
 patents
where one patent can have more than one assignee

Years Active: 1999-2013

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Urea Glucokinase Activators
Obesity Treatments
DPP-IV Inhibitors
Heterocyclic Compounds
Therapeutically Active Compounds
Cis-3,4-Chroman Derivatives
Salicylic Anilides
Pyrrolo[2,1,5-cd]Indolizine Derivatives
19 patents (USPTO):Explore Patents
1. 8362049 - Urea glucokinase activators (2013-01-29),
2. 8318778 - Urea glucokinase activators (2012-11-27),
3. 8022066 - 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes (2011-09-20),
4. 7939690 - Haloalkylsulfone substituted compounds useful for treating obesity and diabetes (2011-05-10),
5. 7915299 - 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes (2011-03-29),
6. 7645791 - Salicylic anilides (2010-01-12),
7. 7235538 - Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV (2007-06-26),
8. 7192952 - Heterocyclic compounds that are inhibitors of the enzyme DPP-IV (2007-03-20),
9. 6869947 - Heterocyclic compounds that are inhibitors of the enzyme DPP-IV (2005-03-22),
10. 6645995 - Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV (2003-11-11),
11. 6380398 - Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV (2002-04-30),
12. 6316494 - cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes (2001-11-13),
13. 6080754 - Pyrrolo[2,1,5-cd]indolizine derivatives useful in the prevention or (2000-06-27),
14. 6075036 - Pyrrolo [2,1,5-cd] indolizine derivatives useful in the prevention or (2000-06-13),
15. 6043269 - cis-3,4-chroman derivatives useful in the prevention or treatment of (2000-03-28),

Title: Inventor Lise Brown Christiansen - Pioneering Innovations in Lyngby

Introduction: Lise Brown Christiansen is a visionary inventor based in Lyngby, Denmark, known for her groundbreaking contributions to various fields through her innovative creations.

Latest Patents: Lise Brown Christiansen holds several patents in the areas of sustainable energy solutions, eco-friendly materials, and advanced healthcare technologies, showcasing her versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Lise Brown Christiansen has established herself as a prominent figure in the world of innovation, with a strong focus on creating solutions that positively impact society and the environment.

Collaborations: Throughout her career, Lise Brown Christiansen has collaborated with leading research institutions, universities, and companies to bring her inventions to life, fostering a culture of creativity and excellence in the innovation landscape.

Conclusion: Lise Brown Christiansen's passion for pushing the boundaries of what is possible through innovation, coupled with her dedication to creating a better future for all, solidifies her legacy as a pioneering inventor in Lyngby and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…